Preliminary Results

Summary by AI BETAClose X

Applied Nutrition reported FY26 revenue up 50.9% to £161.6m, gross profit £71.3m (+44.6%), adjusted EBITDA £43.3m (+40.1%) and adjusted PBT £42.0m (+39.1%), with adjusted EPS 12.5p (+37.4%). Free cash flow fell 35.8% to £10.6m and free cash flow conversion dropped to 33.5% (FY25:72.4%); year-end net cash was £15.9m after c.£12m cash consideration for the Nutrablend US asset acquisition (contributing £1.6m revenue and c.$300m US capacity). Management guides FY27 revenue ~£205m and adjusted EBITDA ~£49m but flags a slight EBITDA margin decline due to lower-margin US sales and higher whey costs; Q1 FY27 trading is reported as strong.

Disclaimer*

UK 100

Latest directors dealings